Cargando…
Treatment of Fabry Disease: Established and Emerging Therapies
Fabry disease (FD) is a rare, X-linked inherited disorder of glycosphingolipid metabolism. It leads to the progressive accumulation of globotriaosylceramide within lysosomes due to a deficiency of α-galactosidase A enzyme. It involves multiple organs, predominantly the renal, cardiac, and cerebrovas...
Autores principales: | Umer, Muhammad, Kalra, Dinesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967779/ https://www.ncbi.nlm.nih.gov/pubmed/37259462 http://dx.doi.org/10.3390/ph16020320 |
Ejemplares similares
-
Cardiac MRI in Fabry disease
por: Umer, Muhammad, et al.
Publicado: (2023) -
Anderson–Fabry Disease: From Endothelial Dysfunction to Emerging Therapies
por: Stamerra, Cosimo A., et al.
Publicado: (2021) -
Chaperone Therapy in Fabry Disease
por: Weidemann, Frank, et al.
Publicado: (2022) -
Pharmacological chaperone therapy for Fabry disease
por: ISHII, Satoshi
Publicado: (2012) -
Multiple phenotypic domains of Fabry disease and their relevance for establishing genotype– phenotype correlations
por: Oliveira, João Paulo, et al.
Publicado: (2019)